The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q4 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
| Rank |
Drug |
Sales ($000) |
|
|
| 1 |
Lipitor
Pfizer Inc |
1,601,663 |
-18.69% |
Stats |
| 2 |
Plavix
Bristol-Myers Squibb Company |
1,575,841 |
-3.38% |
Stats |
| 3 |
Nexium
AstraZeneca Pharmaceuticals |
1,440,333 |
-0.10% |
Stats |
| 4 |
Abilify
Otsuka Pharmaceutical Co. |
1,283,021 |
2.66% |
Stats |
| 5 |
Singulair
Merck & Co., Inc. |
1,139,301 |
2.59% |
Stats |
| 6 |
Seroquel
AstraZeneca Pharmaceuticals |
1,124,163 |
1.71% |
Stats |
| 7 |
Advair Diskus
GlaxoSmithKline |
1,121,157 |
5.66% |
Stats |
| 8 |
Crestor
AstraZeneca Pharmaceuticals |
1,092,260 |
3.69% |
Stats |
| 9 |
Cymbalta
Eli Lilly and Company |
956,723 |
4.70% |
Stats |
10 ( 1) |
Humira
Abbott Laboratories |
905,527 |
3.18% |
Stats |
| 11 (1) |
Enbrel
Amgen Inc. |
873,343 |
1.67% |
Stats |
| 12 (2) |
Neulasta
Amgen Inc. |
822,578 |
4.59% |
Stats |
13 ( 3) |
Remicade
Centocor Ortho Biotech, Inc |
817,365 |
-7.02% |
Stats |
| 14 (2) |
Rituxan
Genentech, Inc |
771,622 |
6.96% |
Stats |
| 15 (3) |
Lexapro
Forest Pharmaceuticals, Inc |
718,613 |
3.12% |
Stats |
| 16 (1) |
Copaxone
Teva Pharmaceuticals |
715,745 |
0.98% |
Stats |
| 17 (2) |
OxyContin
|
669,915 |
-2.58% |
Stats |
| 18 (3) |
Actos
Takeda Pharmaceuticals North America, Inc |
660,834 |
-15.22% |
Stats |
| 19 (1) |
Atripla
Gilead Sciences, Inc. |
657,962 |
4.92% |
Stats |
| 20 (2) |
Epogen
Amgen Inc. |
648,794 |
4.67% |
Stats |
| 21 |
Avastin
Genentech, Inc |
644,570 |
2.86% |
Stats |
| 22 (1) |
Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc |
610,265 |
6.93% |
Stats |
| 23 (1) |
Januvia
Merck & Co., Inc. |
540,947 |
4.87% |
Stats |
24 ( ) |
atorvastatin
Generic |
505,092 |
 |
Stats |
| 25 |
Truvada
Gilead Sciences, Inc. |
504,186 |
3.43% |
Stats |
| 26 (12) |
enoxaparin
Generic |
482,286 |
36.13% |
Stats |
| 27 (1) |
Lantus
Sanofi-Aventis |
474,189 |
0.69% |
Stats |
| 28 (1) |
Diovan
Novartis Corporation |
453,233 |
0.69% |
Stats |
| 29 (11) |
Incivek
Vertex Pharmaceuticals |
446,754 |
33.13% |
Stats |
| 30 (2) |
Lucentis
Genentech, Inc |
439,867 |
2.44% |
Stats |
| 31 (2) |
Lyrica
Pfizer Inc |
432,070 |
1.23% |
Stats |
| 32 (2) |
Celebrex
Pfizer Inc |
426,391 |
1.12% |
Stats |
| 33 (2) |
Herceptin
Genentech, Inc |
425,931 |
7.61% |
Stats |
| 34 |
Lantus Solostar
Sanofi-Aventis |
408,336 |
8.54% |
Stats |
| 35 (4) |
Eloxatin
Sanofi-Aventis |
398,541 |
12.60% |
Stats |
| 36 (1) |
Gleevec
Novartis Corporation |
390,547 |
4.38% |
Stats |
| 37 (1) |
Namenda
Forest Pharmaceuticals, Inc |
381,310 |
6.06% |
Stats |
| 38 (5) |
Avonex
Biogen Idec |
380,189 |
0.19% |
Stats |
| 39 () |
olanzapine
Generic |
379,423 |
|
Stats |
| 40 (8) |
Diovan HCT
Novartis Corporation |
379,367 |
-1.99% |
Stats |
| 41 (28) |
Zyprexa
Eli Lilly and Company |
379,000 |
-54.28% |
Stats |
| 42 (5) |
One Touch Ultra
|
361,509 |
0.66% |
Stats |
| 43 (2) |
Vyvanse
Shire US Inc |
348,645 |
13.05% |
Stats |
| 44 (1) |
Suboxone
Reckitt Benckiser Pharmaceuticals Inc. |
331,741 |
6.35% |
Stats |
| 45 (4) |
Geodon
Pfizer Inc |
330,022 |
-1.27% |
Stats |
| 46 (2) |
Zetia
Merck & Co., Inc. |
320,115 |
2.80% |
Stats |
| 47 |
Provigil
Cephalon, Inc. |
312,978 |
9.48% |
Stats |
| 48 (6) |
TriCor
Abbott Laboratories |
312,497 |
-2.67% |
Stats |
| 49 (3) |
Lidoderm
Endo Pharmaceuticals |
308,945 |
7.01% |
Stats |
| 50 (2) |
methylphenidate
Generic |
303,055 |
16.12% |
Stats |
| 51 () |
Synagis
MedImmune, Inc |
286,731 |
|
Stats |
| 52 (4) |
Combivent
Boehringer Ingelheim Pharmaceuticals, Inc |
282,423 |
10.49% |
Stats |
| 53 (3) |
AndroGel
Abbott Laboratories |
280,432 |
5.44% |
Stats |
| 54 (3) |
amphetamine/dextroamphetamine
Generic |
278,276 |
9.03% |
Stats |
| 55 (2) |
Procrit
Janssen Pharmaceuticals, Inc |
269,937 |
3.58% |
Stats |
| 56 (8) |
Symbicort
AstraZeneca Pharmaceuticals |
267,373 |
11.05% |
Stats |
| 57 (28) |
budesonide
Generic |
266,769 |
51.97% |
Stats |
| 58 (9) |
Niaspan
Abbott Laboratories |
264,055 |
-1.11% |
Stats |
| 59 (4) |
Seroquel XR
AstraZeneca Pharmaceuticals |
261,947 |
2.27% |
Stats |
| 60 (2) |
Alimta
Eli Lilly and Company |
259,810 |
1.82% |
Stats |
| 61 (7) |
Rebif
|
258,643 |
0.43% |
Stats |
| 62 (3) |
Viagra
Pfizer Inc |
257,541 |
1.74% |
Stats |
| 63 (3) |
Novolog
Novo Nordisk Inc. |
252,015 |
0.97% |
Stats |
| 64 (4) |
Nasonex
Merck & Co., Inc. |
251,582 |
9.30% |
Stats |
| 65 (2) |
Humalog
Eli Lilly and Company |
251,367 |
3.78% |
Stats |
| 66 (15) |
Aranesp
Amgen Inc. |
246,056 |
-6.07% |
Stats |
| 67 (5) |
Flovent HFA
GlaxoSmithKline |
245,114 |
15.06% |
Stats |
| 68 (1) |
Lovaza
GlaxoSmithKline |
244,272 |
5.34% |
Stats |
| 69 (3) |
ProAir HFA
Teva Pharmaceuticals |
241,059 |
1.93% |
Stats |
| 70 (5) |
Neupogen
Amgen Inc. |
238,289 |
0.16% |
Stats |
| 71 (10) |
Vytorin
Merck & Co., Inc. |
235,267 |
-3.61% |
Stats |
| 72 (2) |
Reyataz
Bristol-Myers Squibb Company |
234,758 |
3.45% |
Stats |
| 73 (4) |
metoprolol
Generic |
232,625 |
1.20% |
Stats |
| 74 (3) |
Adderall XR
Shire US Inc |
225,825 |
2.80% |
Stats |
| 75 (1) |
Levemir
Novo Nordisk Inc. |
219,295 |
8.66% |
Stats |
| 76 (4) |
NovoLog FlexPen
Novo Nordisk Inc. |
208,552 |
10.19% |
Stats |
| 77 (2) |
Aciphex
Eisai Corporation |
206,760 |
-1.37% |
Stats |
| 78 |
Isentress
Merck & Co., Inc. |
206,451 |
6.07% |
Stats |
| 79 (5) |
fentanyl
Generic |
204,161 |
-2.90% |
Stats |
| 80 (1) |
Cialis
Eli Lilly and Company |
200,494 |
4.24% |
Stats |
| 81 (19) |
Lovenox
Sanofi-Aventis |
197,102 |
-19.10% |
Stats |
| 82 (1) |
Lunesta
Sunovion Pharmaceuticals Inc. |
196,388 |
4.17% |
Stats |
| 83 (1) |
Janumet
Merck & Co., Inc. |
195,470 |
3.95% |
Stats |
| 84 (11) |
Solodyn
Medicis Pharmaceutical Corporation |
194,898 |
-7.87% |
Stats |
| 85 (7) |
Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc |
191,260 |
16.27% |
Stats |
| 86 |
Restasis
Allergan, Inc |
190,745 |
8.79% |
Stats |
| 87 (9) |
acetaminophen/hydrocodone
Generic |
185,206 |
16.09% |
Stats |
| 88 (11) |
Prevnar 13
Wyeth |
181,189 |
-6.93% |
Stats |
| 89 |
Velcade
Takeda Pharmaceuticals North America, Inc |
180,600 |
5.82% |
Stats |
| 90 (42) |
Varivax
Merck & Co., Inc. |
175,987 |
-36.43% |
Stats |
| 91 () |
Pegasys
Genentech, Inc |
174,833 |
|
Stats |
| 92 (2) |
Opana ER
Endo Pharmaceuticals |
173,371 |
7.28% |
Stats |
| 93 (5) |
Zyvox
Pfizer Inc |
172,862 |
1.17% |
Stats |
| 94 (1) |
Benicar
Daiichi Sankyo |
169,877 |
4.87% |
Stats |
| 95 (11) |
Evista
Eli Lilly and Company |
168,353 |
-4.69% |
Stats |
| 96 (5) |
Xeloda
Roche Pharmaceuticals |
168,186 |
1.39% |
Stats |
| 97 (7) |
Erbitux
Bristol-Myers Squibb Company |
167,657 |
-0.15% |
Stats |
| 98 (2) |
Prezista
Janssen Pharmaceuticals, Inc |
167,454 |
7.73% |
Stats |
| 99 (12) |
Betaseron
Bayer Healthcare Pharmaceuticals |
167,236 |
-3.76% |
Stats |
| 100 (1) |
VESIcare
Astellas Pharma US |
163,751 |
4.12% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
1)
3)
)
